Anticonflict and rotarod impairing effects of alprazolam and diazepam in rat after acute and subchronic administration

1. The anticonflict and the rotarod impairing effects of the triazolo-benzodiazepine alprazolam (APZ) and the conventional 1,4-benzodiazepine (BDZ) diazepam (DIZ) were studied in the rat. 2. After acute administration the two drugs displayed approximately equal potency with respect to anticonflict effects in Vogel's conflict test and in Montgomery's conflict test. The results obtained in the former model indicate that also the efficacies of the two drugs are approximately equal. The shapes of the dose response curves obtained in this model differed, however, markedly. Thus, while APZ displayed a wide high efficacy dose-range (0.5-16.0 mg/kg), a maximal effect of DIZ was obtained in a narrow dose-range only (around 4.0 mg/kg). 3. Acutely, APZ was more rotarod impairing than DIZ; total impairment after 2.0 mg/kg of APZ and 3.5 mg/kg of DIZ. 4. After daily treatment with doses producing approximately equal and close to maximal anticonflict effects (APZ 1.25 mg/kg/day; DIZ 3.0 mg/kg/day) tolerance developed to the rotarod impairing (6 days of treatment) and the anticonflict (Vogel's conflict test; 9 days of treatment) effects of both drugs. It appeared, however, as if tolerance was more pronounced to the ataxic/sedative effects (approximately a four-fold rightward shift of the dose-response curve) than to the anticonflict effect (approximately a two-fold shift) of APZ, whereas tolerance developed to about the same extent to the two effects of DIZ (approximately two-fold shifts). 5. In conclusion, for APZ, but not for DIZ, after long-term administration of a dose producing marked anxiolytic-like effects, the relationship anxiolytic-like effect vs. ataxic/sedative effects was altered. These findings offer a tentative explanation to the putative advantage of APZ over conventional BDZs in the treatment of panic disorder.

[1]  Aden Gc,et al.  Alprazolam compared to diazepam and placebo in the treatment of anxiety. , 1980 .

[2]  B. Maletzky Anxiolytic Efficacy of Alprazolam Compared to Diazepam and Placebo , 1980, The Journal of international medical research.

[3]  Y. Take,et al.  Pharmacological studies on new potent central depressants, 8-chloro-6-phenyl-4H-s-triazolo [4,3a][1,4] benzodiazepine (D-40tA) and its 1-methyl analogue (D-65MT). , 1971, Japanese journal of pharmacology.

[4]  M. Lader,et al.  Physiological and psychological effects of clorazepate in man. , 1980, British journal of clinical pharmacology.

[5]  D. Greenblatt,et al.  Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. , 1984, Journal of clinical psychopharmacology.

[6]  J. Hinrichs,et al.  Diazepam and propranolol in panic disorder and agoraphobia. , 1984, Archives of general psychiatry.

[7]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[8]  J. Cohn Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients. , 1981, The Journal of clinical psychiatry.

[9]  S. File Tolerance to the behavioral actions of benzodiazepines , 1985, Neuroscience & Biobehavioral Reviews.

[10]  K. Rickels,et al.  Benzodiazepines for treatment of panic attacks: a new look. , 1986, Psychopharmacology bulletin.

[11]  J. Gorman,et al.  Alprazolam in the treatment of panic disorders. , 1986, Journal of clinical psychopharmacology.

[12]  S. File,et al.  Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat , 1986, Pharmacology Biochemistry and Behavior.

[13]  R. N. Brogden,et al.  Alprazolam , 1984, Drugs.

[14]  H. Melsom,et al.  Diazepam metabolism in normal man. II. Serum concentration and clinical effect after oral administration and cumulation. , 1974, Clinical pharmacology and therapeutics.

[15]  L. Hollister,et al.  Functional tolerance to alprazolam-induced neurologic deficits in mice. , 1984, Life sciences.

[16]  S. File Development and retention of tolerance to the sedative effects of chlordiazepoxide: role of apparatus cues. , 1982, European journal of pharmacology.

[17]  D. Treit Evidence that tolerance develops to the anxiolytic effect of diazepam in rats , 1985, Pharmacology Biochemistry and Behavior.

[18]  S. Hjorth,et al.  Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). , 1984, European journal of pharmacology.

[19]  P. Vonvoigtlander,et al.  Alprazolam: Review of pharmacological, pharmacokinetic, and clinical data , 1985 .